Intra-individual Variability of Serum Aldosterone and Implications for Primary Aldosteronism Screening
The Journal of Clinical Endocrinology & Metabolism · 13.04.2023 · 108 (5) · 1143-1153
DOI: 10.1210/clinem/dgac679 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 22.11.2022. Verfasst von Ana Alice W Maciel und 25 weiteren Autor:innen. Beteiligte Einrichtung: Unidade de Adrenal, Laboratório de Hormônios e Genética Molecular LIM/42, Serviço de Endocrinologia e Metabologia, Hospital das Clínicas, Faculdade d…. Hauptthemen laut MEDLINE: Hyperaldosteronism, Hypertension. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: São Paulo Research Foundation.
Abstract (Originalsprache)
Context
Primary aldosteronism (PA) screening relies on an elevated aldosterone to renin ratio with a minimum aldosterone level, which varies from 10 to 15 ng/dL (277-415.5 pmol/L) using immunoassay.
Objective
To evaluate intra-individual coefficient of variation (CV) of aldosterone and aldosterone to direct renin concentration ratio (A/DRC) and its impact on PA screening.
Methods
A total of 671 aldosterone and DRC measurements were performed by the same chemiluminescence assays in a large cohort of 216 patients with confirmed PA and at least 2 screenings.
Results
The median intra-individual CV of aldosterone and A/DRC was 26.8% and 26.7%. Almost 40% of the patients had at least one aldosterone level <15 ng/dL, 19.9% had at least 2 aldosterone levels <15 ng/dL, and 16.2% had mean aldosterone levels <15 ng/dL. A lower cutoff of 10 ng/dL was associated with false negative rates for PA screening of 14.3% for a single aldosterone measurement, 4.6% for 2 aldosterone measurements, and only 2.3% for mean aldosterone levels. Considering the minimum aldosterone, true positive rate of aldosterone thresholds was 85.7% for 10 ng/dL and 61.6% for 15 ng/dL. An A/DRC >2 ng/dL/µIU/mL had a true positive rate for PA diagnosis of 94.4% and 98.4% when based on 1 or 2 assessments, respectively. CV of aldosterone and A/DRC were not affected by sex, use of interfering antihypertensive medications, PA lateralization, hypokalemia, age, and number of hormone measurements.
Conclusion
Aldosterone concentrations had a high CV in PA patients, which results in an elevated rate of false negatives in a single screening for PA. Therefore, PA screening should be based on at least 2 screenings with concomitant aldosterone and renin measurements.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Unidade de Adrenal, Laboratório de Hormônios e Genética Molecular LIM/42, Serviço de Endocrinologia e Metabologia, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo, São Paulo, 05403-000, Brasil.
- Disciplina de Endocrinologia, Departamento de Clínica Médica, Faculdade de Medicina da Universidade Federal de Uberlândia, Uberlândia, Minas Gerais, 38400-902, Brasil.
- Departamento de Patologia, Faculdade de Medicina da Universidade de São Paulo, São Paulo, 05403-000, Brasil.
- Divisão de Urologia, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo, São Paulo, 05403-000, Brasil.
- Instituto de Radiologia InRad, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo, São Paulo, 05403-000, Brasil.
- Unidade de Hipertensão, Instituto do Coração (InCor), Faculdade de Medicina da Universidade de São Paulo, São Paulo, 05403-900, Brasil.
ORCID-Profile: Maria Candida B V Fragoso, Madson Q Almeida
Förderung
- São Paulo Research Foundation
Zitieren
APA
Maciel, A. A. W., Freitas, T. C., Fagundes, G. F. C., Petenuci, J., Vilela, L. A. P., Brito, L. P., Goldbaum, T. S., Zerbini, M. C. N., Ledesma, F. L., Tanno, F. Y., Srougi, V., Chambo, J. L., Pereira, M. A. A., Coelho, F. M. A., Cavalcante, A. C. B. S., Carnevale, F. C., Pilan, B., Pio-Abreu, A., Silveira, J. V., …, & Almeida, M. Q. (2023). Intra-individual Variability of Serum Aldosterone and Implications for Primary Aldosteronism Screening. The Journal of Clinical Endocrinology & Metabolism, 108(5), 1143-1153. https://doi.org/10.1210/clinem/dgac679
Vancouver
Maciel AAW, Freitas TC, Fagundes GFC, Petenuci J, Vilela LAP, Brito LP, et al. Intra-individual Variability of Serum Aldosterone and Implications for Primary Aldosteronism Screening. The Journal of Clinical Endocrinology & Metabolism. 2023;108(5):1143-1153. doi:10.1210/clinem/dgac679
BibTeX
@article{Maciel2023,
author = {Maciel, Ana Alice W and Freitas, Thais C and Fagundes, Gustavo F C and Petenuci, Janaina and Vilela, Leticia A P and Brito, Luciana P and Goldbaum, Tatiana S and Zerbini, Maria Claudia N and Ledesma, Felipe L and Tanno, Fabio Y and Srougi, Victor and Chambo, Jose L and Pereira, Maria Adelaide A and Coelho, Fernando M A and Cavalcante, Aline C B S and Carnevale, Francisco C and Pilan, Bruna and Pio-Abreu, Andrea and Silveira, João V and Consolim-Colombo, Fernanda M and Bortolotto, Luiz A and Latronico, Ana Claudia and Fragoso, Maria Candida B V and Drager, Luciano F and Mendonca, Berenice B and Almeida, Madson Q},
title = {Intra-individual Variability of Serum Aldosterone and Implications for Primary Aldosteronism Screening},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2023},
volume = {108},
number = {5},
pages = {1143--1153},
doi = {10.1210/clinem/dgac679}
}
EUVIMED